Iovance Biotherapeutics, Inc. kompaniyasidagi eng so‘nggi ish o‘rinlari

Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc.
1 Indekslangan ish o‘rinlari
Tashkil topgan yil 2014
501 – 1 000 Xodimlar
BiotexnologiyaFarmatsevtika mahsulotlariSog‘liqni saqlash
Iovance Biotherapeutics, Inc. develops personalized cancer cell therapies that use a patient’s immune cells to target cancer. Its work centers on tumor-infiltrating lymphocyte (TIL) therapy, which aims to restore the cancer-fighting activity of immune cells found within tumors. Iovance is studying TIL treatments in clinical trials for advanced solid tumors and advancing genetically modified TIL approaches, alongside research into peripheral blood lymphocyte therapies for blood cancers. The biotechnology company also operates a cell therapy manufacturing center in Philadelphia.

Filtrlar

Iovance Biotherapeutics, Inc.

Clinical Trial Manager, Remote – Iovance Biotherapeutics

Iovance Biotherapeutics, Inc.

Lead clinical operations for Iovance’s tumor-infiltrating lymphocyte therapies across registrational trials. Coordinate vendors, data quality, budgets, timelines, and regulatory compliance.

Ochish